Herbalife (NYSE:HLF) Price Target Raised to $9.00 at Mizuho

Herbalife (NYSE:HLF - Get Free Report) had its price target lifted by research analysts at Mizuho from $8.00 to $9.00 in a report issued on Friday, Benzinga reports. The firm currently has a "neutral" rating on the stock. Mizuho's price objective would indicate a potential upside of 14.50% from the company's previous close.

Several other brokerages have also commented on HLF. Citigroup lowered their price objective on shares of Herbalife from $16.00 to $13.00 and set a "buy" rating for the company in a report on Friday, October 25th. B. Riley lowered their target price on Herbalife from $17.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday. StockNews.com cut Herbalife from a "buy" rating to a "hold" rating in a research note on Tuesday, October 22nd. Finally, DA Davidson lowered their price objective on Herbalife from $13.00 to $7.50 and set a "neutral" rating for the company in a research report on Thursday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $10.42.

Herbalife Price Performance

Herbalife stock traded up $0.31 during trading hours on Friday, reaching $7.86. The stock had a trading volume of 5,074,810 shares, compared to its average volume of 2,116,499. The company has a fifty day simple moving average of $7.33 and a 200-day simple moving average of $9.29. Herbalife has a 52 week low of $6.59 and a 52 week high of $15.66. The stock has a market cap of $791.66 million, a PE ratio of 9.18, a PEG ratio of 0.26 and a beta of 1.19.

Herbalife (NYSE:HLF - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.38. Herbalife had a negative return on equity of 18.25% and a net margin of 1.73%. The company had revenue of $1.24 billion for the quarter, compared to analysts' expectations of $1.23 billion. Research analysts predict that Herbalife will post 1.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Herbalife

In other Herbalife news, Director Juan Miguel Mendoza acquired 10,000 shares of the company's stock in a transaction dated Monday, August 26th. The stock was purchased at an average price of $8.72 per share, with a total value of $87,200.00. Following the completion of the purchase, the director now directly owns 110,000 shares in the company, valued at approximately $959,200. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.94% of the company's stock.

Hedge Funds Weigh In On Herbalife

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Baupost Group LLC MA boosted its stake in Herbalife by 128.3% during the second quarter. Baupost Group LLC MA now owns 5,124,526 shares of the company's stock valued at $53,244,000 after buying an additional 2,879,603 shares during the last quarter. Marshall Wace LLP increased its stake in Herbalife by 2,053.6% in the second quarter. Marshall Wace LLP now owns 1,977,155 shares of the company's stock worth $20,543,000 after purchasing an additional 1,885,346 shares during the period. Jacobs Levy Equity Management Inc. lifted its position in shares of Herbalife by 3,832.5% during the first quarter. Jacobs Levy Equity Management Inc. now owns 1,157,309 shares of the company's stock worth $11,631,000 after purchasing an additional 1,127,880 shares during the last quarter. Renaissance Technologies LLC boosted its stake in shares of Herbalife by 11.6% during the second quarter. Renaissance Technologies LLC now owns 6,653,401 shares of the company's stock valued at $69,129,000 after purchasing an additional 692,800 shares during the period. Finally, Iridian Asset Management LLC CT grew its holdings in shares of Herbalife by 43.7% in the third quarter. Iridian Asset Management LLC CT now owns 2,228,193 shares of the company's stock worth $16,021,000 after purchasing an additional 677,739 shares during the last quarter.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.